Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor

American Journal of Pathology

Volumn 169, Issue 2, 2006, Pages 643-654

  Marcellini, Marcella ^a   De Luca, Naomi ^b   Riccioni, Teresa ^a   Ciucci, Alessandro ^c   Orecchia, Angela ^b   Lacal, Pedro Miguel ^b   Ruffini, Federica ^b   Pesce, Maurizio ^d   Cianfarani, Francesca ^b   Zambruno, Giovanna ^b   Orlandi, Augusto ^c   Failla, Cristina Maria ^b  

^a Sigma Tau SpA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; MATRIX METALLOPROTEINASE; PLACENTAL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER GROWTH; CELL INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 33746602209     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051041     Document Type: Article

References (42)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
2. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Hessing B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MAS, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201
3. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994, 5:89-97
4. Graeven U, Fiedler W, Karpinski S: Melanoma-associated expression of vascular endothelial growth factor and its receptors Flt-1 and KDR. J Cancer Res Clin Oncol 1999, 125:621-629
5. Gitay-Goren H, Halaban R, Neufeld G: Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun 1993, 190:702-709
6. Lacal P, Failla CM, Pagani E, Odorisio T, Schietroma C, Cianfarani F, Falcinelli S, Zambruno G, D'Atri S: Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000, 115:1000-1007
7. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189
8. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert J, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt-1. Nat Med 2002, 8:831-840
9. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2:289-300
10. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D: VEGFR-1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827
11. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7:575-583
12. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem 1996, 271:17629-17634
13. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MAS, Werb Z, Lyden D, Rafii S: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment. Nat Med 2002, 8:841-849
14. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bone F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P: Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt-1 and Flk-1. Nat Med 2003, 9:936-943
15. Kodama J, Seki N, Tokumo K, Nakanishi Y, Yoshinouchi M, Kudo T: Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. Eur J Gynaecol Oncol 1997, 18:508-510
16. Donnini S, Machein MR, Plate KH, Weich HA: Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. J Pathol 1999, 189:66-71
17. Adini A, Kornaga T, Firoozbakht F, Benjamin LE: Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002, 62:2749-2752
18. DiSalvo J, Bayne M, Conn G, Kwok P, Trivedi P, Soderman D, Palisi T, Sullivan K, Thomas K: Purification and characterization of a naturally occurring vascular endothelial growth factor/placenta growth factor heterodimer. J Biol Chem 1995, 270:7717-7723
19. Cao Y, Linden P, Shima D, Browne F, Folkman J: In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 1996, 98:2507-2511
20. Failla CM, Odorisio T, Cianfarani F, Schietroma C, Puddu P, Zambruno G: Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 2000, 115:388-395
21. Eriksson A, Cao R, Pawliuk R, Berg S, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y: Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002, 1:99-108
22. Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G: Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 2002, 115:2559-2567
23. Gimbrone MA: Culture of vascular endothelium. Prog Hemost Thromb 1976, 3:1-28
24. Wirtz MK, Glanville RW, Steinmann B, Rao VH, Hollister DW: Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2 (I) chain. J Biol Chem 1987, 262:16376-16385
25. Skehan P, Stoneng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107-1112
26. Orecchia A, Lacal PM, Schietroma C, Morea V, Zambruno G, Failla CM: Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the α5β1 integrin. J Cell Sci 2003, 116:3479-3489
27. Lacal PM, Ruffini F, Pagani E, D'Atri S: An autocrine loop directed by the vascular endothelial growth factor promoted invasiveness of human melanoma cells. Int J Oncol 2005, 27:1625-1632
28. Dejana E, Corada M, Lampugnani MG: Endothelial cell-to-cell junctions. FASEB J 1995, 9:910-918
29. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999, 154:1381-1390
30. Kahn J, Byk T, Jansson-Sjostrad L, Petit I, Shivtiel S, Nagler A, Hardan I, Deutsch V, Gazit Z, Gazit D, Karlsson S, Lapidot T: Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004, 103:2942-2949
31. Handsley MM, Edwards DR: Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005, 115:849-860
32. Ferrara N, Gerber H, LeCourter J: The biology of VEGF and its receptors. Nat Med 2003, 9:669-676
33. Nagy JA, Dvorak AM, Dvorak HF: VEGF-A (164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med 2003, 13:169-175
34. Taylor AP, Rodriguez M, Adams K, Goldenberg DM, Blumenthal RD: Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence. Int J Cancer 2003, 105:158-164
35. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ: Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994-1998
36. Lu W, Schroit AJ: Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency. Cancer Res 2005, 65:913-918
37. Tamarat R, Silvestre J-S, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Lévy BI: Impairment in ischemia-induced neovascularization in diabetes. Am J Pathol 2004, 164:457-466
38. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S: Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 2001, 938:36-45
39. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, Decarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett 2006, 236:39-45
40. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998, 58:1048-1051
41. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ: Contributions of stromal metalloproteinase-9 to angiogenesis and growth of ovarian carcinoma in mice. J Natl Cancer Inst 2002, 94:1134-1142
42. Hofmann UB, Eggert AAO, Blass K, Brocker E-B, Becker JC: Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res 2003, 63:8221-8225